Biogen Stock Drops Premarket_老虎社区_美港股上老虎

Biogen Stock Drops Premarket

The Wall Street Journal2021-06-24

Biogen shares dropped over 7% in premarket trading. The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

814f811
·2021-06-25
yes
回复
点赞
举报
angell20
·2021-06-25
cool
回复
点赞
举报
foxkeh
·2021-06-25
Baddd
回复
1
举报
Fai_Lee
·2021-06-24
👍🏼
回复
1
举报
BiErGaiShi
·2021-06-24
buy the dip? it should drop further
回复
4
举报
Roychai
·2021-06-24
Awesome
回复
点赞
举报
Marcurzed
·2021-06-24
Great
回复
点赞
举报
viktar
·2021-06-24
It needs to drop a bit more for rebuy
回复
1
举报
lkt
·2021-06-24
Great
回复
点赞
举报
Bartchen
·2021-06-24
Drop more
回复
点赞
举报
lkt
·2021-06-24
Opportunity
回复
1
举报
SirBahamut
·2021-06-24
Like my comment pls thanks
回复
1
举报
收起
- LianLing:
  Done
  2021-06-24
  回复
  举报
kt888
·2021-06-24
,,
回复
1
举报
huat2021
·2021-06-24
Up
回复
点赞
举报
收起
- kt888:
  ya
  2021-06-24
  回复
  举报
agjh
·2021-06-24
Great
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1154733193?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-24 20:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154733193","market":"us","top_or_hot":-1,"title":"Biogen Stock Drops Premarket","media":"The Wall Street Journal","content":"<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","article_id":"1154733193","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","pubTimestamp":1624536552,"sourceInfo":null,"weMediaInfo":null,"summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","collect":0,"end_time":0,"defaultTopTitle":"wsj.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"上市前生物原库存下降","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":0.9},"content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":126871279,"gmtCreate":1624553801591,"gmtModify":1634004405102,"author":{"id":"3571293257474839","authorId":"3571293257474839","authorIdStr":"3571293257474839","name":"814f811","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3571293257474839"},"htmlText":"yes","listText":"yes","text":"yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126871279","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126856583,"gmtCreate":1624552467642,"gmtModify":1634004419341,"author":{"id":"3582344262517249","authorId":"3582344262517249","authorIdStr":"3582344262517249","name":"angell20","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582344262517249"},"htmlText":"cool","listText":"cool","text":"cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126856583","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126836037,"gmtCreate":1624550552329,"gmtModify":1634004460435,"author":{"id":"3572820167428371","authorId":"3572820167428371","authorIdStr":"3572820167428371","name":"foxkeh","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3572820167428371"},"htmlText":"Baddd","listText":"Baddd","text":"Baddd","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126836037","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126131902,"gmtCreate":1624546974306,"gmtModify":1634004533064,"author":{"id":"3586221024979214","authorId":"3586221024979214","authorIdStr":"3586221024979214","name":"Fai_Lee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586221024979214"},"htmlText":"👍🏼","listText":"👍🏼","text":"👍🏼","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126131902","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126027852,"gmtCreate":1624538912276,"gmtModify":1634004714492,"author":{"id":"3530266091749222","authorId":"3530266091749222","authorIdStr":"3530266091749222","name":"BiErGaiShi","avatar":"https://static.tigerbbs.com/a6fe5dbcb2f892246515b13cb7c68a10","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3530266091749222"},"htmlText":"buy the dip? it should drop further&nbsp;","listText":"buy the dip? it should drop further&nbsp;","text":"buy the dip? it should drop further","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126027852","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126021535,"gmtCreate":1624538508527,"gmtModify":1634004719658,"author":{"id":"3576464999632889","authorId":"3576464999632889","authorIdStr":"3576464999632889","name":"Roychai","avatar":"https://static.tigerbbs.com/b4d2ecfef49d3ba20a60dcca96f2b1d4","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3576464999632889"},"htmlText":"Awesome","listText":"Awesome","text":"Awesome","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126021535","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126029283,"gmtCreate":1624538381042,"gmtModify":1634004721158,"author":{"id":"4087628888775460","authorId":"4087628888775460","authorIdStr":"4087628888775460","name":"Marcurzed","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4087628888775460"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126029283","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126065874,"gmtCreate":1624538160798,"gmtModify":1634004724142,"author":{"id":"4087130985557480","authorId":"4087130985557480","authorIdStr":"4087130985557480","name":"viktar","avatar":"https://static.tigerbbs.com/cefa1ac93e2a54bbead7b08d30201b0b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4087130985557480"},"htmlText":"It needs to drop a bit more for rebuy&nbsp;","listText":"It needs to drop a bit more for rebuy&nbsp;","text":"It needs to drop a bit more for rebuy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126065874","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126086806,"gmtCreate":1624537652005,"gmtModify":1634004733609,"author":{"id":"3583895118447399","authorId":"3583895118447399","authorIdStr":"3583895118447399","name":"lkt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583895118447399"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126086806","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126086992,"gmtCreate":1624537633516,"gmtModify":1634004733856,"author":{"id":"3581493327878373","authorId":"3581493327878373","authorIdStr":"3581493327878373","name":"Bartchen","avatar":"https://static.tigerbbs.com/7ebe9ebb1352fc339d8fce5528e369bb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581493327878373"},"htmlText":"Drop more","listText":"Drop more","text":"Drop more","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126086992","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126081090,"gmtCreate":1624537535010,"gmtModify":1634004735658,"author":{"id":"3583895118447399","authorId":"3583895118447399","authorIdStr":"3583895118447399","name":"lkt","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3583895118447399"},"htmlText":"Opportunity","listText":"Opportunity","text":"Opportunity","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126081090","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126015222,"gmtCreate":1624537336566,"gmtModify":1634004739474,"author":{"id":"3581734227956830","authorId":"3581734227956830","authorIdStr":"3581734227956830","name":"SirBahamut","avatar":"https://static.tigerbbs.com/98035de918c1759870078e69640b8281","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581734227956830"},"htmlText":"Like my comment pls thanks","listText":"Like my comment pls thanks","text":"Like my comment pls thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/126015222","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4996284,"gmtCreate":1624540641530,"gmtModify":1635248315094,"authorId":3577507935392188,"author":{"id":3577507935392188,"authorId":3577507935392188,"name":"LianLing","avatar":"https://static.tigerbbs.com/68a86fa228a8c77edcca2d0ffba4f6f4","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126015222,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"}],"langContent":"EN"},{"id":126019257,"gmtCreate":1624537079679,"gmtModify":1631892320596,"author":{"id":"3577583042847869","authorId":"3577583042847869","authorIdStr":"3577583042847869","name":"kt888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3577583042847869"},"htmlText":",,","listText":",,","text":",,","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126019257","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126034051,"gmtCreate":1624536962273,"gmtModify":1634004747577,"author":{"id":"3583729514558900","authorId":"3583729514558900","authorIdStr":"3583729514558900","name":"huat2021","avatar":"https://static.tigerbbs.com/49b895c30667640daa563c9df795792c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583729514558900"},"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/126034051","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4995443,"gmtCreate":1624537094165,"gmtModify":1635248388440,"authorId":3577583042847869,"author":{"id":3577583042847869,"authorId":3577583042847869,"name":"kt888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126034051,"type":1,"supId":0,"prevId":0,"content":"ya","text":"ya","html":"ya"}],"langContent":"EN"},{"id":126038430,"gmtCreate":1624536824820,"gmtModify":1634004749981,"author":{"id":"3573384172885142","authorId":"3573384172885142","authorIdStr":"3573384172885142","name":"agjh","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3573384172885142"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126038430","repostId":1154733193,"repostType":4,"repost":{"id":"1154733193","pubTimestamp":1624536552,"share":"https://www.laohu8.com/m/news/1154733193?lang=&edition=full","pubTime":"2021-06-24 20:09","market":"us","language":"en","title":"Biogen Stock Drops Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1154733193","media":"The Wall Street Journal","summary":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its sta","content":"<p>Biogen shares dropped over 7% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/03125372f62e0f168465fa41a7405a57\" tg-width=\"658\" tg-height=\"440\"></p>\n<p>The stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&amp;P 500's roughly 13% advance.</p>\n<p>The drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen Stock Drops Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen Stock Drops Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/dxN6UHk54SMgjBK70YIp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154733193","content_text":"Biogen shares dropped over 7% in premarket trading.\n\nThe stock has soared since the FDA gave its stamp of approval for an Alzheimer's drug from Biogen earlier this month. As of Wednesday close, the stock was up over 50% this year, compared with the S&P 500's roughly 13% advance.\nThe drug would be the first new treatment for the disease in decades. But the FDA approval has been mired in controversy, with the agency's own statisticians saying there was insufficient evidence to support approval.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":72,"commentSize":15,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}